0001209191-23-050890.txt : 20230929
0001209191-23-050890.hdr.sgml : 20230929
20230929200222
ACCESSION NUMBER: 0001209191-23-050890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230927
FILED AS OF DATE: 20230929
DATE AS OF CHANGE: 20230929
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hansard Adam
CENTRAL INDEX KEY: 0001805556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 231297299
MAIL ADDRESS:
STREET 1: C/O APPLIED THERAPEUTICS, INC.
STREET 2: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-27
0
0001697532
Applied Therapeutics Inc.
APLT
0001805556
Hansard Adam
C/O APPLIED THERAPEUTICS, INC.
545 FIFTH AVENUE, SUITE 1400
NEW YORK
NY
10017
0
1
0
0
Chief Commercial Officer
0
Common Stock
2023-09-27
4
S
0
9720
2.70
D
382755
D
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
/s/ Shoshana Shendelman, Attorney-in-Fact
2023-09-29